{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T03:05:13Z","timestamp":1789095913309,"version":"build-2803163510"},"reference-count":59,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004087","name":"Shizuoka University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004087","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["21K08069"],"award-info":[{"award-number":["21K08069"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["24K02216"],"award-info":[{"award-number":["24K02216"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["20K07070"],"award-info":[{"award-number":["20K07070"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["19K16396"],"award-info":[{"award-number":["19K16396"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001695","name":"Japan Science and Technology Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001695","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["23mk0101189h0303"],"award-info":[{"award-number":["23mk0101189h0303"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["22mk0101189h0302"],"award-info":[{"award-number":["22mk0101189h0302"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jphs.2025.03.011","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T18:35:21Z","timestamp":1742409321000},"page":"84-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The citrus flavonoid nobiletin prevents the development of doxorubicin-induced heart failure by inhibiting apoptosis"],"prefix":"10.1016","volume":"158","author":[{"given":"Yoichi","family":"Sunagawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonoka","family":"Iwashimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saho","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenshiro","family":"Iwashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Funamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kana","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihide","family":"Hamabe-Horiike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasufumi","family":"Katanasaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Asakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Inai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Komiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Hawke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Arakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuho","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Kurokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7054-4447","authenticated-orcid":false,"given":"Tatsuya","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jphs.2025.03.011_bib2","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/bjh.14708","article-title":"A retrospective analysis of 3954 patients in phase 2\/3 trials of bortezomib for the treatment of multiple myeloma: towards providing a benchmark for the cardiac safety profile of proteasome inhibition in multiple myeloma","volume":"178","author":"Laubach","year":"2017","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.jphs.2025.03.011_bib3","first-page":"363","article-title":"Cancer treatment and survivorship statistics, 2019","volume":"69","author":"Miller","year":"2019","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"10.1016\/j.jphs.2025.03.011_bib4","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaoncol.2015.0735","article-title":"The global burden of cancer 2013","volume":"1","author":"Fitzmaurice","year":"2015","journal-title":"JAMA Oncol"},{"issue":"3","key":"10.1016\/j.jphs.2025.03.011_bib5","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jacc.2009.03.095","article-title":"Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy","volume":"55","author":"Cardinale","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jphs.2025.03.011_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.120117","article-title":"Liposomal doxorubicin as targeted delivery platform: current trends in surface functionalization","volume":"593","author":"Makwana","year":"2021","journal-title":"Int J Pharm"},{"issue":"15","key":"10.1016\/j.jphs.2025.03.011_bib8","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.3390\/molecules26154447","article-title":"Biopharmaceutical study on nobiletin-loaded amorphous solid dispersion with improved hypouricemic effect","volume":"26","author":"Nihei","year":"2021","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.jphs.2025.03.011_bib9","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1161\/CIR.0000000000000556","article-title":"Cardiovascular disease and breast cancer: where these entities intersect: a scientific statement from the American heart association","volume":"137","author":"Mehta","year":"2018","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.jphs.2025.03.011_bib10","article-title":"Breast cancer and the cardiovascular disease: a narrative review","volume":"14","author":"Cherukuri","year":"2022","journal-title":"Cureus"},{"issue":"22","key":"10.1016\/j.jphs.2025.03.011_bib11","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","article-title":"Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy","volume":"131","author":"Cardinale","year":"2015","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jphs.2025.03.011_bib12","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1161\/CIR.0000000000000986","article-title":"Recognition, prevention, and management of arrhythmias and autonomic disorders in cardio-oncology: a scientific statement from the American heart association","volume":"144","author":"Fradley","year":"2021","journal-title":"Circulation"},{"issue":"36","key":"10.1016\/j.jphs.2025.03.011_bib13","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","article-title":"ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)","volume":"37","author":"Zamorano","year":"2016","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.jphs.2025.03.011_bib14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.annonc.2019.10.023","article-title":"Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations","volume":"31","author":"Curigliano","year":"2020","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.jphs.2025.03.011_bib15","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3390\/molecules23040877","article-title":"An overview of novel dietary supplements and food ingredients in patients with metabolic syndrome and non-alcoholic fatty liver disease","volume":"23","author":"Silva Figueiredo","year":"2018","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.jphs.2025.03.011_bib16","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3390\/cancers14030683","article-title":"Chrysanthemum morifolium extract ameliorates doxorubicin-induced cardiotoxicity by decreasing apoptosis","volume":"14","author":"Ono","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jphs.2025.03.011_bib17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.phymed.2018.01.009","article-title":"Recent progress in doxorubicin-induced cardiotoxicity and protective potential of natural products","volume":"40","author":"Yu","year":"2018","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jphs.2025.03.011_bib18","doi-asserted-by":"crossref","DOI":"10.1007\/s10753-019-01123-w","article-title":"Nobiletin protects from renal ischemia-reperfusion injury in rats by suppressing inflammatory cytokines and regulating iNOS-eNOS expressions","author":"G\u00fcven\u00e7","year":"2020","journal-title":"Inflammation"},{"issue":"6","key":"10.1016\/j.jphs.2025.03.011_bib19","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3390\/cancers11060867","article-title":"Nobiletin and derivatives: functional compounds from citrus fruit peel for colon cancer chemoprevention","volume":"11","author":"Goh","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.jphs.2025.03.011_bib20","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.2337\/db10-0589","article-title":"Nobiletin attenuates VLDL overproduction, dyslipidemia, and atherosclerosis in mice with diet-induced insulin resistance","volume":"60","author":"Mulvihill","year":"2011","journal-title":"Diabetes"},{"issue":"18","key":"10.1016\/j.jphs.2025.03.011_bib21","first-page":"5059","article-title":"Inhibitory effect of citrus nobiletin on phorbol ester-induced skin inflammation, oxidative stress, and tumor promotion in Mice1","volume":"60","author":"Murakami","year":"2000","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.jphs.2025.03.011_bib22","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.bbadis.2016.05.006","article-title":"Tyrosine phosphorylation of RACK1 triggers cardiomyocyte hypertrophy by regulating the interaction between p300 and GATA4","volume":"1862","author":"Suzuki","year":"2016","journal-title":"Biochim Biophys Acta"},{"issue":"13","key":"10.1016\/j.jphs.2025.03.011_bib23","doi-asserted-by":"crossref","first-page":"9556","DOI":"10.1074\/jbc.M109.070458","article-title":"Cyclin-dependent kinase-9 is a component of the p300\/GATA4 complex required for phenylephrine-induced hypertrophy in cardiomyocytes","volume":"285","author":"Sunagawa","year":"2010","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.jphs.2025.03.011_bib24","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.7150\/ijbs.65664","article-title":"Multimerization of the GATA4 transcription factor regulates transcriptional activity and cardiomyocyte hypertrophic response","volume":"18","author":"Shimizu","year":"2022","journal-title":"Int J Biol Sci"},{"issue":"1","key":"10.1016\/j.jphs.2025.03.011_bib25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"issue":"18","key":"10.1016\/j.jphs.2025.03.011_bib26","doi-asserted-by":"crossref","first-page":"13721","DOI":"10.1074\/jbc.275.18.13721","article-title":"Phosphorylation of GATA-4 is involved in alpha 1-adrenergic agonist-responsive transcription of the endothelin-1 gene in cardiac myocytes","volume":"275","author":"Morimoto","year":"2000","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.jphs.2025.03.011_bib27","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.3390\/ijms22041771","article-title":"Histone acetylation domains are differentially induced during development of heart failure in dahl salt-sensitive rats","volume":"22","author":"Funamoto","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jphs.2025.03.011_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153744","article-title":"Zerumbone prevents pressure overload-induced left ventricular systolic dysfunction by inhibiting cardiac hypertrophy and fibrosis","volume":"92","author":"Sari","year":"2021","journal-title":"Phytomedicine"},{"issue":"4","key":"10.1016\/j.jphs.2025.03.011_bib29","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jphs.2019.08.005","article-title":"Continued exposure of anti-cancer drugs to human iPS cell-derived cardiomyocytes can unmask their cardiotoxic effects","volume":"140","author":"Sakamoto","year":"2019","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.jphs.2025.03.011_bib30","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.yjmcc.2014.09.010","article-title":"Image-based evaluation of contraction\u2013relaxation kinetics of human-induced pluripotent stem cell-derived cardiomyocytes: correlation and complementarity with extracellular electrophysiology","volume":"77","author":"Hayakawa","year":"2014","journal-title":"J Mol Cell Cardiol"},{"issue":"17","key":"10.1016\/j.jphs.2025.03.011_bib31","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1055\/a-1191-7970","article-title":"Cacao bean polyphenols inhibit cardiac hypertrophy and systolic dysfunction in pressure overload-induced heart failure model mice","volume":"86","author":"Sari","year":"2020","journal-title":"Planta Med"},{"issue":"12","key":"10.1016\/j.jphs.2025.03.011_bib32","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.3390\/ph14121268","article-title":"The selective serotonin 2A receptor antagonist sarpogrelate prevents cardiac hypertrophy and systolic dysfunction via inhibition of the ERK1\/2-GATA4 signaling pathway","volume":"14","author":"Shimizu","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"issue":"3","key":"10.1016\/j.jphs.2025.03.011_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/nu14030580","article-title":"Ecklonia stolonifera okamura extract suppresses myocardial infarction-induced left ventricular systolic dysfunction by inhibiting p300-HAT activity","volume":"14","author":"Katagiri","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.jphs.2025.03.011_bib34","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ejphar.2017.10.043","article-title":"Molecular mechanism of doxorubicin-induced cardiomyopathy - an update","volume":"818","author":"Renu","year":"2018","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"10.1016\/j.jphs.2025.03.011_bib35","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1161\/CIRCRESAHA.119.314681","article-title":"Mitochondrial determinants of doxorubicin-induced cardiomyopathy","volume":"126","author":"Wallace","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.jphs.2025.03.011_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111708","article-title":"Doxorubicin-induced cardiotoxicity: an update on the molecular mechanism and novel therapeutic strategies for effective management","volume":"139","author":"Rawat","year":"2021","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"10.1016\/j.jphs.2025.03.011_bib37","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nm.4087","article-title":"Human induced pluripotent stem cell\u2013derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity","volume":"22","author":"Burridge","year":"2016","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.jphs.2025.03.011_bib38","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.stemcr.2017.08.025","article-title":"Efficient large-scale 2D culture system for human induced pluripotent stem cells and differentiated cardiomyocytes","volume":"9","author":"Tohyama","year":"2017","journal-title":"Stem Cell Rep"},{"issue":"2","key":"10.1016\/j.jphs.2025.03.011_bib39","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jphs.2024.07.007","article-title":"Inorganic sulfides prevent osimertinib-induced mitochondrial dysfunction in human iPS cell-derived cardiomyocytes","volume":"156","author":"Kondo","year":"2024","journal-title":"J Pharmacol Sci"},{"issue":"2","key":"10.1016\/j.jphs.2025.03.011_bib40","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1254\/jphs.FP0050980","article-title":"Doxorubicin induces apoptosis by activation of caspase-3 in cultured cardiomyocytes in vitro and rat cardiac ventricles in vivo","volume":"101","author":"Ueno","year":"2006","journal-title":"J Pharmacol Sci"},{"issue":"4","key":"10.1016\/j.jphs.2025.03.011_bib41","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41419-021-03614-x","article-title":"Regulated cell death pathways in doxorubicin-induced cardiotoxicity","volume":"12","author":"Christidi","year":"2021","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.jphs.2025.03.011_bib42","doi-asserted-by":"crossref","first-page":"73","DOI":"10.5607\/en20051","article-title":"Nobiletin exhibits neuroprotective effects against mitochondrial complex I inhibition via regulating apoptotic signaling","volume":"30","author":"Amarsanaa","year":"2021","journal-title":"Exp Neurobiol"},{"issue":"1","key":"10.1016\/j.jphs.2025.03.011_bib43","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12011-020-02038-6","article-title":"Nobiletin regulates ROS\/ADMA\/DDAHII\/eNOS\/NO pathway and alleviates vascular endothelium injury by iron overload","volume":"198","author":"Wang","year":"2020","journal-title":"Biol Trace Elem Res"},{"key":"10.1016\/j.jphs.2025.03.011_bib44","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.intimp.2019.04.060","article-title":"Nobiletin ameliorates myocardial ischemia and reperfusion injury by attenuating endoplasmic reticulum stress-associated apoptosis through regulation of the PI3K\/AKT signal pathway","volume":"73","author":"Zhang","year":"2019","journal-title":"Int Immunopharmacol"},{"issue":"9","key":"10.1016\/j.jphs.2025.03.011_bib45","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00210-019-01661-y","article-title":"Nobiletin protects against myocardial injury and myocardial apoptosis following coronary microembolization via activating PI3K\/Akt pathway in rats","volume":"392","author":"Mao","year":"2019","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.jphs.2025.03.011_bib46","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejphar.2019.03.056","article-title":"Nobiletin suppresses oxidative stress and apoptosis in H9c2 cardiomyocytes following hypoxia\/reoxygenation injury","volume":"854","author":"Liu","year":"2019","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"10.1016\/j.jphs.2025.03.011_bib47","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/FJC.0000000000001333","article-title":"Gab1 overexpression alleviates doxorubicin-induced cardiac oxidative stress, inflammation, and apoptosis through PI3K\/akt signaling pathway","volume":"80","author":"Zhang","year":"2022","journal-title":"J Cardiovasc Pharmacol"},{"issue":"8","key":"10.1016\/j.jphs.2025.03.011_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135438","article-title":"Insulin protects cardiac myocytes from doxorubicin toxicity by Sp1-mediated transactivation of survivin","volume":"10","author":"Lee","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jphs.2025.03.011_bib49","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3892\/mmr.2021.11938","article-title":"Hydrogen sulfide ameliorates doxorubicin-induced myocardial fibrosis in rats via the PI3K\/AKT\/mTOR pathway","volume":"23","author":"Nie","year":"2021","journal-title":"Mol Med Rep"},{"issue":"4","key":"10.1016\/j.jphs.2025.03.011_bib50","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1159\/000478960","article-title":"Nobiletin, a polymethoxy flavonoid, protects against cardiac hypertrophy induced by pressure-overload via inhibition of NAPDH oxidases and endoplasmic reticulum stress","volume":"42","author":"Zhang","year":"2017","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"10.1016\/j.jphs.2025.03.011_bib51","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11010-016-2716-z","article-title":"Nobiletin attenuates cardiac dysfunction, oxidative stress, and inflammatory in streptozotocin: induced diabetic cardiomyopathy","volume":"417","author":"Zhang","year":"2016","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"10.1016\/j.jphs.2025.03.011_bib52","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.bbrc.2017.08.064","article-title":"Nobiletin attenuates adverse cardiac remodeling after acute myocardial infarction in rats via restoring autophagy flux","volume":"492","author":"Wu","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.jphs.2025.03.011_bib53","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/fsn3.953","article-title":"Nobiletin induces growth inhibition and apoptosis in human nasopharyngeal carcinoma C666-1 cells through regulating PARP-2\/SIRT1\/AMPK signaling pathway","volume":"7","author":"Zheng","year":"2019","journal-title":"Food Sci Nutr"},{"key":"10.1016\/j.jphs.2025.03.011_bib54","doi-asserted-by":"crossref","DOI":"10.29219\/fnr.v62.1323","article-title":"Nobiletin inhibits breast cancer via p38 mitogen-activated protein kinase, nuclear transcription factor-\u03baB, and nuclear factor erythroid 2-related factor 2 pathways in MCF-7 cells","volume":"62","author":"Liu","year":"2018","journal-title":"Food Nutr Res"},{"issue":"1","key":"10.1016\/j.jphs.2025.03.011_bib55","doi-asserted-by":"crossref","DOI":"10.1038\/srep18789","article-title":"Nobiletin enhances the efficacy of chemotherapeutic agents in ABCB1 overexpression cancer cells","volume":"5","author":"Ma","year":"2015","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.jphs.2025.03.011_bib56","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.3390\/nu10121829","article-title":"Nobiletin enhances chemosensitivity to adriamycin through modulation of the Akt\/GSK3\u03b2\/\u03b2\u2212Catenin\/MYCN\/MRP1 signaling pathway in A549 human non-small-cell lung cancer cells","volume":"10","author":"Moon","year":"2018","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.jphs.2025.03.011_bib57","article-title":"Molecular mechanism of natural food antioxidants to regulate ROS in treating cancer: a review","volume":"13","author":"Muchtaridi","year":"2024","journal-title":"Antioxidants (Basel)"},{"issue":"6","key":"10.1016\/j.jphs.2025.03.011_bib58","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.fct.2010.04.007","article-title":"New advances in molecular mechanisms and the prevention of adriamycin toxicity by antioxidant nutrients","volume":"48","author":"Granados-Principal","year":"2010","journal-title":"Food Chem Toxicol"},{"issue":"9","key":"10.1016\/j.jphs.2025.03.011_bib59","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1007\/s00432-017-2464-9","article-title":"ROS-modulated therapeutic approaches in cancer treatment","volume":"143","author":"Raza","year":"2017","journal-title":"J Cancer Res Clin Oncol"},{"issue":"5","key":"10.1016\/j.jphs.2025.03.011_bib60","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/carcin\/bgy043","article-title":"DNA methylome and transcriptome alterations and cancer prevention by curcumin in colitis-accelerated colon cancer in mice","volume":"39","author":"Guo","year":"2018","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jphs.2025.03.011_bib61","article-title":"Antioxidants with two faces toward cancer","volume":"258","author":"Dastmalchi","year":"2020","journal-title":"Life Sci"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861325000325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861325000325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T18:51:42Z","timestamp":1762368702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861325000325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1347861325000325"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2025.03.011","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The citrus flavonoid nobiletin prevents the development of doxorubicin-induced heart failure by inhibiting apoptosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2025.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}